extraction and fractionation in effect-directed analysis · fractionation, biotesting and nontarget...
TRANSCRIPT
Extraction and Fractionationin Effect-Directed Analysis
Martin Krauss & Werner Brack
Department Effect-Directed Analysis,
Helmholtz Centre for Environmental Research - UFZ,
Leipzig, Germany
EDA @ UFZ
Main focus on:
Identification &
assessment
of toxicants in
complex mixtures
Mainly
sediments & water
Our EDA approach
Biologicalanalysis
Biologicalanalysis
Chemicalanalysis
Fractionation
Confirmation
Toxicant
Complex
Sample
Extraction
Extraction
Exhaustive extractions result in heavy matrix load: cleanup required
“Total” concentrations
do not account for real exposition situation in sediments
do not consider bioavailability (bioaccessibility) of compounds
Extraction and preconcentration
are essential for biotesting (& chemical analysis)
Water samples:
Solid-phase extraction / (liquid-liquid extraction)
Sediment samples:
Solvent extraction / Pressurized liquid extraction (ASE)
Effect of cleanup on biotest result
Mutagenicity of sediment extracts spiked with Benzo(a)pyren
Ames fluctuation assay TA98 + S9
Masking of mutagenicity by matrix (cytotoxicity, …)
Loss of BaP (& other mutagens?) by GPC
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 --
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 200.0
0.2
0.4
0.6
0.8
1.0Bitterfeld
inh
ibit
ion
ASE
TENAX
pe -
Green algae growth inhibition of sediment extract fractions
non-bioaccessible
PAHs
NH
N-phenyl-2-naphthylamine
Sch
wab e
t al., E
T&
C, 20
09
Considering bioavailability in extraction
TENAX extraction:
Rapidly desorbable fraction
Zhao & Pignatello, 2004
Extraction
EDA on sediments EDA on food
Matrix removal / cleanup
is often necessary
Cleanup methods are
available
Including bioaccessibility is
relevant for realistic exposure
Concepts and methods are
available
Matrix removal / cleanup
is necessary
Cleanup methods are
available or transferable
Is bioavailability an issue?
If yes, different concepts and
methods have to be applied
25.00 30.00 35.00
100 200 300
260
130
268
239134
100 300200
TIME
A
B
Extract
F2.5.8
Fractionation helps to
dramatically reduce
complexity
O
S
Fractionation
Wanted:
� Individual fractions with low overlap and high recovery
� Separation according to well defined properties → helps to identify compounds
� High throughput (many samples/time) and high capacity
(much sample)
Reducing complexity by fractionation
Colum Chromatography/Solid-phase extraction
(Semi-)preparative LC
Preparative capillary GC
NP-LC (NO -Phenyl)2
F2.1
.1 n
icht
h
alo
genie
rt
F2.1
.2
F2.1
.3
F2.1
.4
F2.1
.5 F2.1
.6
F2.1
.7 F2.1
.8
F2.1
.9
F2.1
.10
F
2.1
.11
Elektrondonor-Akzeptor-LC (PYE)
EXTRAKT
F1: unpolareAliphaten
F2: unpolare Aromaten
F3, F4: polareFraktionen
Säulenchromatographie (Al O ) 2 3
F2.1 PCDD/Fs
PCBs, PCNs
F2.2 PAHs
MW 152-166F2.3 PAHs
Mw178
F2.4 PAHs
MW 202
F2.5 PAHs
MW 226/228
F2.6 PAHs
MW 252
PAHs
MW 276>
PCBs: Cl + , ortho Cl - Tetra- bis Octa- CN, CDD/F
F1.8
.2 T
CD
F,
F1.8
.1T
CD
D,
F1.8
.3 P
eC
N
F1.9
.3 H
xC
N
F1.9
.2 P
eC
DF
F1.9
.1 P
eC
DD
F1.1
0.1
H
xCD
D
F1.1
0.2
H
xCD
F
F1.1
0.3
HpC
N
Größenausschluss-LC
Brack et al. J Chrom A (2003)
Reducing complexity by complex fractionation
AhR-receptor mediated toxicity of a sediment extract
NP-LC (NO -Phenyl)2
F2.5
.1
e.g
. TR
PF
2.5.
2 e.
g. B
aA
F2.
5.3
e.g
. C
HR
F2.5
.4 e.g
. 2M
BaA
F2.5
.5
e.g
. 10M
BaA
F2.5
.6 e
.g. 4M
CH
RF
2.5.7
e
.g. 3M
CH
RF
2.5
.8
e.g
. 9M
BaA
F2.
5.9
e
.g. 2M
CH
RF
2.5
.10
e
.g. 121
2D
NF
RP-LC (C18, endcapped, Polymer)
EXTRAKT
F1: unpolareAliphaten
F2: unpolare Aromaten
F3, F4: polareFraktionen
Säulenchromatographie (Al O ) 2 3
RP-LC (PYE)
F2.1 PCDD/Fs PCBs, PCNs
F2.2 PAHsMW 152-166
F2.3 PAHsMw178
F2.4 PAHsMW 202
F2.5 PAHsMW 226/228
F2.6 PAHsMW 252
PAHsMW 276>
F2.5.8.1 9MBaA
F2.5.8.2 22NBT
F2.5.8.3 2123DNF
F2.5.8.4 1MCHR
Reducing complexity by complex fractionation
AhR-receptor mediated toxicity of a sediment extract
Brack et al. J Chrom A (2003)
PyrenylNitrophenyl
PyrenylNitrophenyl
PyrenylNitrophenyl chlorinated diaromatic compounds (PCBs, PCDDs/Fs)
alkanes, alkenes, sulphur, non-planar diaromatic compounds
Sampleinjection keto-, hydroxy-, nitro-PAHs,
N-heterocyclic PACs, quinones
Nitrophenyl stationary phase (NO)
Porous Graphitised Carbon stationary phase (PGC)
Cyanopropyl stationary phase (CN)
N
CH 3
CH3
N+
O-
O
Step 1
Step 2
Step 3-5
PAHs, S-, O-heterocyclic PACs
Functional groups
CN
NO
PGC electron-rich surface
High effort of fractionation procedure
⇒ on-line combination of three different NP-columns
Lübcke-von Varel et al. 2008 J Chrom A 1185:31-42
Reducing complexity by fractionation
Results in 18 fractions
0
20
40
60
80
100
120
P1
P2
P3
P4
P5
P6
P7
P8
P9
P10
P11
P12
P13
P14
P15
P16
P17
P18
fractions
% o
f contr
ol
0
500
1000
1500
2000
2500
3000
3500
4000
P1
P2
P3
P4
P5
P6
P7
P8
P9
P1
0
P1
1
P1
2
P1
3
P1
4
P1
5
P1
6
P1
7
P1
8
pm
ol T
4 e
q/g
dry
sed
imen
t
0
5
10
15
20
25
30
35
40
P 1
P 2
P 3
P 4
P 5
P 6
P 7
P 8
P 9
P 1
0
P 1
1
P 1
2
P 1
3
P 1
4
P 1
5
P 1
6
P 1
7
P 1
8
% m
axim
um
in
du
cti
on
thyroid
hormone
disturbing
potency
estrogenicity
tumor promotion
(inhibition of GJIC)
0
10
20
30
40
50
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
nu
mb
er
of
po
sit
ive w
ells
TA98
TA98 with metabolic
activation
mutagenicity
PCBs, PCDD/Fs, halogenated pesticides
PAHs polar compounds
Multi-endpoint EDA in Elbe sediment extracts
Lübcke-von Varel 2011, ES&T 45:2348
Polar compounds play dominant role for adverse effects of sediment contamination.
Page 14
N+
O-
O
N+
O-
O
N+
O-
O
N+O
-
O
F14.6
Two fractionation steps later(RP-C18, followed by NP-Pyrenyl):
1.8-dinitropyrene 1,6-dinitropyrene
Isolation and quantitative confirmation of 1,8- and 1,6-dinitropyrene
as cause of mutagenicity.
Significant contributorsto mutagenicity of other fractions:
N+
O-
O
N+
O-
O
1,3-dinitropyrene
3-nitrobenz-anthrone
Lübcke-von Varel 2012, Environ. Int. 45, 31
Multi-endpoint EDA in Elbe sediment extracts
Fractionation
EDA on sediments EDA on food
Fractionation is successful to
isolate toxicants and allow
identification
Fractionation methods are
available
Fractionation will be necessary
to isolate unknown toxicants
and allow identification
Fractionation methods are
transferable
Page 16
br_extrac t_pos 28.07.2009 10:23:05 PM
RT: 0.00 - 75.01
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75
Tim e (m in)
0
10
20
30
40
50
60
70
80
90
100
Rela
tive A
bundance
28.97
4.36
3.43
4.9242.90
5.86 28.13 35.11 44.58 48.48 49.0842.396.32 24.36 40.42 55.3233.06 58.6321.248.03 59.2814.27 19.83 62.68
3.04 66.16 73.51
NL:
9.29E7
TIC F : FTM S + p
A PCI c orona Full
m s
[100.00-400.00]
M S
br_ex trac t_pos
br_ex trac t_pos #30-6966 RT: 0.34-74.58 AV : 1734 NL: 5.62E5
F: FTM S + p A PCI corona Full m s [100.00-400.00]
120 140 160 180 200 220 240 260 280 300 320 340 360 380 400
m /z
0
5
10
15
20
25
Rela
tive A
bundance
163.04130.16
117.09
344.34
395.37
283.26 376.29134.06 251.05187.04171.15 369.35205.09 341.21
111.04
327.20
150.03
277.09212.12 289.09 298.31379.34237.08
221.10
193.12 313.27
LC-HRMS: about 10 000 masses
detected, mostly unknowns
Mutagenic extract of water
sample in the River Elbe
A full scale EDA example
Bases
Cation
exchange
Acids & neutrals
Anion
exchange
Acids NeutralsBases
0.00
5.00
10.00
15.00
20.00
25.00
30.00
35.00
40.00
45.00
50.00
Acid fraction Basic fraction Neutral fraction
Nu
mb
er
of
Re
ve
rta
nts
pe
r p
late
(m
ax
=4
8) Without S9
With S9
Reducing complexity by fractionation
Mutagenic extract of water sample from River Elbe
Mutageniticy (Ames fluctuation assay, TA98)
0
5
10
15
20
25
30
35
40
45
N1 N2 N3 N4 N5 N6 N7 N8 N9 N10 N11
Num
ber
of
revert
ents
10 g of BR without S9
10 g of BR with S9
N2 mutagenic only with
activation, fraction eluted early
⇨ more hydrophilic compounds
N7 mutagenic only without activation, fraction eluted later
⇨ more lipophilic compounds
LIPOPHILICITY
Reducing complexity by fractionation
Neutral
fraction
Prep LC
C18 column
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
16.00
18.00
20.00
N2-1 N2-2 N2-3 N2-4 N2-5 N2-6 N2-7 N2-8 N2-9 N2-10 N2-11 N2-12 N2-13 N2-14 N2-15 N2-16
Nu
mb
er
of
revert
an
ts p
er
pla
te (
max=
48)
10 g of BR with S9
5 g of BR with S9
Three mutagenic fractions, N2-8 same number of revertants for 10 and 5 g of BR
⇒ Priority for the identification, 20-60 peaks per fraction
Reducing complexity by fractionation
Prep LCPhenyl-Hexyl
column
• Accurate mass
• Isotope patterns
• Accurate mass fragments
LC-HRMS(n)
Molecular formula
e.g. C13H10O2N2S• Spectral libraries
• Compound databases
(e.g., ChemSpider)
• Structure generation
(MOLGEN) Large number of
candidate structures
Step 1: Identification of candidate structures
Compound identification in the EDA context
SEITE 21
Predicted mutagenic potential
Retention timeprediction
MS fragmentation
prediction
Predicted KOW- and
pKa-values of fractions
Eff
ect-
based
2 Peaks with one candidate
each for aromatic aminesFinal Candidates
Confirm Identity & Effect
Ch
em
ical-
an
aly
ticall
y b
ased
20 Peaks,
5-150 Candidate structures
Aromatic amines
Predicted mutagenic potential
Stability of the Nitrenium ion of arom. amine
• Nitrenium ion is ultimate mutagen after metabolic
activation
• Stability of nitrenium ion is correlated with mutagenicity
P450Ar-NH2 ArNH+
Mutagenicity likely if
(∆∆∆∆EArNH+−∆−∆−∆−∆EArNH2) < (∆∆∆∆EPhNH+−∆−∆−∆−∆EPhNH2)
Aromatic Amines likely
Comparison of strains TA98 / YG1024 / YG1041
Step 2: Selection of candidates
Compound identification in the EDA context
Where are we now in EDA
Our EDA approach is working and the combination of fractionation, biotesting and nontarget chemical analysis is suitable to identify toxicants
No routine application, but site- and case-specific
Time- and resource-consuming:
large amount of sample material
large number of fractions to be tested and analyzed
Automatization of sample extraction & fractionation
Miniaturized and automated biotests would be very useful
5.00 10.00 15.00 20.00 25.00 30.00 35.000
500000
1000000
1500000
2000000
2500000
3000000
3500000
4000000
4500000
5000000
5500000
6000000
6500000
7000000
7500000
8000000
8500000
9000000
9500000
1e+07
Time-->
Abundance
TIC: WER046.D
mut
agen
TA98m
utage
n TA
98 + S
9
mut
agen
TAM
ixm
utag
en T
AMix
+ S
9
estro
gen
andro
gen
anti-a
ndro
gendi
oxin-
like
thyr
oid
antib
iotic
Pardubice
Přelouč
Jirkow
Most
Jorba
Martorell
St. Joan Despí
Rundvaartbrug
Eenhoorn
Hansweert
Terneuzen
Making EDA easier for many samples
Use multivariate statistics to precede and guide
“classical EDA” approach
multivariate analysis of chemical and biological fingerprints
Current developments
Funding
TxB X